Under pressure to succeed
The life sciences industry, viewed as the great hope for the future, is being counted on to conquer the pandemic with vaccines. How did it manage to ramp up vaccine production so rapidly?
“The partnership-based relationships with pharmaceutical companies and biotech startups, plus the experience we have gained, are now reaping dividends. We’re helping to create the required production capacity in hundreds of projects around the globe at a record pace,” says Klaus Köhler.
The industry manager points out that although the industrial manufacture of mRNA vaccines is new, “in terms of production technology most of the steps are similar to those used for recombinant vaccines”. Endress+Hauser has delivered thousands of measurement instruments in recent months that now monitor these manufacturing processes worldwide. “Anyone who gets vaccinated in Europe – or in fact around the globe – can be fairly sure that the vaccine was produced with the help of instruments from Endress+Hauser,” adds Klaus Köhler.